Treatment Of Oropharyngeal Candidiasis By Oravig (Miconazole) Buccal Tablets

Treatment Of Oropharyngeal Candidiasis By Oravig (Miconazole) Buccal Tablets.
Strativa Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Oravig (miconazole) buccal tablets for the healing of oropharyngeal candidiasis (OPC), more commonly known as thrush, in adults and children life-span 16 and older weightloss. Oravig is the in the first place and only local, vocalized formula formulation of miconazole - an antifungal medication - approved for this use in the US.

Oravig, which adheres to the gum, utilizes innovative buccal notebook technology enabling once-daily dosing that delivers miconazole immediately at the limited spot of infection throughout the epoch with tiniest systemic absorption tryvimax.com. Oravig is easy-to-use and provides patients with a flavorless, odorless and within treatment option that does not interfere with everyday activities such as eating and drinking.

Oravig will be offered in a 50 mg dosage ability and is expected to be available in retail pharmacies in the third leniency of 2010. "The FDA approval of Oravig underscores Strativa's commitment to improving patients' overall curing experience by bringing to retail new products that fulfill patient needs," said John A MacPhee, President, Strativa Pharmaceuticals. "Oravig offers patients agony from thrush a proven in operation therapy in a discreet and convenient once-daily formulation".

The FDA approbation was based on two pivotal Phase III clinical trials. The initial study demonstrated that Oravig and sinker resolved signs and symptoms of OPC at rates similar to Mycelex Troche (clotrimazole) administered five times per broad daylight in HIV-positive patients. This randomized, double-blind, double-dummy plague was conducted in 577 HIV-positive patients in 28 sites in the United States, Canada, and South Africa. A twinkling randomized, open-label, multicenter comparative check conducted in 282 patients who underwent radiotherapy for make a beeline for and neck cancer showed that Oravig is all right and operational in this patient population who often has reduced salivary flow.